Besifloxacin ophthalmic suspension

besifloxacin · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Besifloxacin ophthalmic suspension, covering 2012-03-29 to 2012-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis [Phase 2, Phase 3]